6 things to know about the $1.9B spinal biologics market

By Laura Dyrda

A new report from MarketsandMarkets shows the spinal biologics market is expected to grow over the next five years.

Here are five key notes:

Advertisement

1. The market was valued at $1.9 billion in 2014 and expected to grow at a compound annual growth rate of 4.4 percent through 2020 to reach $2.4 billion.

READ MORE HERE

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement